GC Genome Corporation (KOSDAQ:340450)
6,900.00
-100.00 (-1.43%)
Sep 18, 2026, 3:30 PM KST
| Market Cap | 163.19B -14.9% |
| Revenue (ttm) | 32.64B +13.7% |
| Net Income | 5.42B +41,017.6% |
| EPS | 229.79 +33,590.0% |
| Shares Out | 23.65M |
| PE Ratio | 30.03 |
| Forward PE | 30.13 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 147,346 |
| Open | 7,010.00 |
| Previous Close | 7,000.00 |
| Day's Range | 6,710.00 - 7,010.00 |
| 52-Week Range | 4,100.00 - 9,520.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Apr 10, 2026 |